Diabetes Type 3, which is regarded as ”brain specific,” is not completely understood and remains a mystery.
Diagnosis and treatments remain in the early stages, and more studies are required in order to fully understand how to help those with diabetes Type 3 as well as its connection to Alzheimer’s and dementia.
However, a new product called CinGx may stimulate an insulin receptor protein which can assist in the treatment of Type 3 Diabetes, Alzheimer’s disease (AD) and levels of dementia.
Diabetes increases the risk of Alzheimer’s disease by up to 65%.
There is currently no cure for Diabetes.
IT CAN ONLY BE TREATED OR PREVENTED.
Allegiance Equity has developed CinGx.